Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
GRAIL, Inc. trades on Nasdaq under the ticker GRAL. The company belongs to the Health care sector. The trading history on this page starts on 12 June 2024.
Over the past 52 weeks GRAL has traded between 41.50 $ and 166.48 $. As of 09 October 2026 the price stood 72.90 % of the way from the 52-week low to the high.
Over one year GRAL shares rose 111.10 %; over six months they rose 178.83 %. Volatility over 90 days is 88.50 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 34.9, above the sector median of 3.9. Price to book is 2.2, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 130.00 | 134.56 | 127.46 | 132.61 | 1M |
| 07 October 2026 | 134.00 | 139.00 | 130.56 | 132.90 | 992,500 |
| 06 October 2026 | 159.43 | 166.48 | 135.80 | 137.28 | 2M |
| 05 October 2026 | 143.00 | 156.49 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
GRAIL, Inc. (GRAL) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 147.2m $, net income was -408.4m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:1525 O'BRIEN DRIVE, MENLO PARK, CA, 94025, US
GRAIL, Inc. reported revenue of 156M $ and a net loss of 395M $ over the last four quarters. Net margin is −253.22 %. Revenue changed by +19.44 % year over year. Earnings per share are −10.30 $. Market capitalisation is 5.5B $.
GRAL has a return on equity of −15.81 %, above the sector median of −41.68 %. Return on assets is −14.10 %, above the sector median of −32.11 %. Operating margin is −348.66 %, below the sector median of −26.84 %.
| 245M |
| CAICaris Life Sciences, Inc. | 29.62 | +7.71 % | 145M |
| CELCCelcuity Inc. | 67.68 | −0.28 % | 90M |
| CDNACareDx, Inc. | 63.71 | +2.42 % | 80M |
| BLLNBillionToOne, Inc. | 98.28 | +3.01 % | 66M |
| 140.31 |
| 154.08 |
| 1M |
| 02 October 2026 | 135.52 | 143.50 | 134.45 | 143.26 | 873,800 |
| 01 October 2026 | 138.23 | 141.54 | 132.04 | 132.56 | 1M |
| 30 September 2026 | 138.27 | 151.46 | 136.00 | 140.12 | 2M |
| 29 September 2026 | 132.75 | 140.88 | 131.20 | 136.57 | 920,600 |
| 28 September 2026 | 128.90 | 134.42 | 126.74 | 132.63 | 1M |
| 25 September 2026 | 123.50 | 127.67 | 118.45 | 126.89 | 1M |
| 24 September 2026 | 105.50 | 126.81 | 101.98 | 125.21 | 3M |
| 23 September 2026 | 108.52 | 108.52 | 108.52 | 108.52 | 0 |
| 22 September 2026 | 106.75 | 112.58 | 104.00 | 108.52 | 3M |
| 21 September 2026 | 93.74 | 111.50 | 92.00 | 107.97 | 4M |
| 18 September 2026 | 81.48 | 82.85 | 78.20 | 80.77 | 3M |
| 17 September 2026 | 75.29 | 81.76 | 75.29 | 79.95 | 2M |
| 16 September 2026 | 75.95 | 78.86 | 74.12 | 75.11 | 2M |
| 15 September 2026 | 75.44 | 77.93 | 74.27 | 75.89 | 2M |
| 14 September 2026 | 74.68 | 76.56 | 73.46 | 75.53 | 1M |
| 11 September 2026 | 77.61 | 79.19 | 76.14 | 76.23 | 360,900 |